- Home
- NVAX vs VEON Comparison
NVAX vs VEON Comparison
Compare NVAX & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- VEON
- Stock Information
- Founded
- NVAX 1987
- VEON 1992
- Country
- NVAX United States
- VEON United Arab Emirates
- Employees
- NVAX N/A
- VEON N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- VEON Telecommunications Equipment
- Sector
- NVAX Health Care
- VEON Telecommunications
- Exchange
- NVAX Nasdaq
- VEON Nasdaq
- Market Cap
- NVAX 1.3B
- VEON 3.8B
- IPO Year
- NVAX 1995
- VEON 1996
- Fundamental
- Price
- NVAX $8.39
- VEON $52.20
- Analyst Decision
- NVAX Buy
- VEON Strong Buy
- Analyst Count
- NVAX 7
- VEON 1
- Target Price
- NVAX $14.29
- VEON $60.00
- AVG Volume (30 Days)
- NVAX 6.8M
- VEON 197.1K
- Earning Date
- NVAX 11-11-2025
- VEON 11-13-2025
- Dividend Yield
- NVAX N/A
- VEON N/A
- EPS Growth
- NVAX N/A
- VEON N/A
- EPS
- NVAX 2.54
- VEON 13.63
- Revenue
- NVAX $1,078,718,000.00
- VEON $4,148,000,000.00
- Revenue This Year
- NVAX $61.69
- VEON $10.26
- Revenue Next Year
- NVAX N/A
- VEON $7.02
- P/E Ratio
- NVAX $3.30
- VEON $3.86
- Revenue Growth
- NVAX 9.22
- VEON 7.27
- 52 Week Low
- NVAX $5.01
- VEON $27.95
- 52 Week High
- NVAX $15.22
- VEON $64.00
- Technical
- Relative Strength Index (RSI)
- NVAX 56.61
- VEON 43.26
- Support Level
- NVAX $7.83
- VEON $50.00
- Resistance Level
- NVAX $8.31
- VEON $55.06
- Average True Range (ATR)
- NVAX 0.38
- VEON 2.78
- MACD
- NVAX 0.05
- VEON -0.66
- Stochastic Oscillator
- NVAX 74.84
- VEON 16.55
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.